期刊文献+

神经内分泌分化对前列腺癌细胞生长及雄激素受体表达影响的实验研究 被引量:4

The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells
原文传递
导出
摘要 目的探讨神经内分泌分化对前列腺癌细胞生长的作用及对雄激素受体表达的影响。方法建立神经内分泌分化的前列腺癌细胞模型PC3MNE和LNCaPNE;采用甲基噻唑基四唑(MTT)试验观察其调节前列腺癌细胞生长的作用[以吸光度值(A)表示];采用逆转录聚合酶链反应和Western杂交方法检测LNCaPNE对LNCaP细胞雄激素受体表达的影响。结果PC3MNE的培养上清液可促进PC3M细胞的生长(A值在培养24h为034±018与050±009,48h为038±016与057±009,72h为038±015与055±005,P均<005);在有雄激素时,LNCaPNE的培养上清液不促进LNCaP细胞的生长,对其雄激素受体的表达也没有显著影响;去除雄激素后,LNCaPNE的培养上清液可促进LNCaP细胞的生长,并能下调其雄激素受体的表达(P均<005)。结论在雄激素阻断后,神经内分泌分化的前列腺癌细胞能以旁分泌的方式支持其他前列腺癌细胞生长,降低其雄激素受体的表达。 Objective To study the paracrine effect of the neuroendocrine differentiation cells and its influence on androgen receptor expression of prostate carcinoma cells. Methods Established an in vitro induced model of neuroendocrine differentiation of prostate carcinoma (LNCaP NE , PC 3M NE ), and investigate the proliferation effect of neuroendocrine phenotype cells (LNCaP NE , PC 3M NE ) on other non neuroendocrine phenotype cells (LNCaP, PC 3M) by feeding non neuroendocrine phenotype cells with the medium pre incubated with induced neuroendocrine phenotype cells. It was also tested the regulation of androgen receptor mRNA and androgen receptor protein expression of LNCaP NE cells on LNCaP cells by reverse transcriptase polymerase chain reaction and Western Blot in the presence or absence of androgens. Results The medium pre incubated with PC 3M NE cells could promote the proliferation of PC 3M cells. The medium pre incubated with LNCaP NE cells could promote the proliferation of LNCaP cells, and reduce the expression of androgen receptor in the latter in the absence of androgens, but the negative results were observed in the presence of androgens. Conclusions The neuroendocrine phenotype cells of prostate cancer can reduce the expression of androgen receptor in prostate cancer cells and promote them to proliferate by means of paracrine in the blockade of androgens.
出处 《中华外科杂志》 CAS CSCD 北大核心 2004年第23期1453-1456,共4页 Chinese Journal of Surgery
  • 相关文献

参考文献6

  • 1Bang YJ, Pirnia F, Fang WG, et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A, 1994, 91:5330-5334.
  • 2Grant ES, Batchelor KW, Habib FK. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression. Prostate, 1996, 29: 339-349.
  • 3Abrahamsson PA, Falkmer S, Falt K, et al. The course of neuroendocrine differentiation in prostatic carcinomas: an immunohistochemical study testing chromogranin A as an ''endocrine marker''. Pathol Res Pract, 1989, 185:373-380.
  • 4Tarle M, Ahel M, Kovacic K. Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients. Anticancer Research, 2002, 22:2525-2529.
  • 5Bonkhoff H, Wernert N, Dhom G, et al. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate, 1991, 19:91-98.
  • 6Jongsma J, Oomen MH, Noordzij MA, et al. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate, 2000, 42:34-44.

同被引文献77

  • 1牛亦农,辛殿祺,何志嵩,周利群,潘柏年,那彦群,郭应禄.短期新辅助治疗对前列腺癌组织内聚集素蛋白表达的影响[J].中华外科杂志,2005,43(6):394-397. 被引量:2
  • 2姜涛,姜辉,宋希双,李宪承,李泉林.前列腺癌中P53的表达及其临床意义[J].中华男科学杂志,2005,11(6):448-451. 被引量:11
  • 3丁涛,车文骏,陈同珏.前列腺癌组织中性激素受体表达的分析[J].中华男科学杂志,2006,12(1):50-52. 被引量:9
  • 4叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 5SCHRODER F H. Progress in understanding androgenindependent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms[J]. Eur Urol, 2008, 53(6): 1129-1137.
  • 6CHOW C. OncomiRs: the discovery and progress of microRNAs in cancers[J].Mol Cancer, 2007, 6: 60.
  • 7BONKHOFF H, FIXEMER T. Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype[J]. Pathologe, 2005, 26 (6) 453-460.
  • 8MURATA T, TAKAYAMA K, KATAYAMA S, et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression[J]. Prostate Cancer Prostatic Dis, 2010,13 (4) : 356-361.
  • 9FUJITA Y, KOJIMA K, OHHASHI R, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drugresistant prostate cancer PC3 cells by regulating MSK1 expression[J]. J Biol Chem, 2010, 285(25):19076-19084.
  • 10ZHANG B, PAN X, COBB G P, et al. microRNAs as oncogenes and tumor suppressors[J]. Dev Biol, 2007, 302 (1): 1-12.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部